Uncategorized

We estimate that iRhythm (IRTC) faces a 1%-2% growth headwind from a finalized local coverage determination (LCD) on ambulatory cardiac monitoring (ACM), likely to be released in the coming weeks. While we expect the company’s…

With government policy in flux and CY/FY27 payment updates coming into focus, we outline key 2Q potential policy catalysts and debates for health insurers and providers. While CMS’s improved CY27 Medicare Advantage rates offer a…

We had the following takeaways from last week’s conference call we hosted on the recent verdicts in the META and GOOGL trials in New Mexico and California with two lawyers who are very familiar with similar Internet cases. A transcript or audio recording of the call is available…

The final CY27 Medicare Advantage (MA) rate announcement, reflecting a net 2.48% YoY benchmark increase, landed within our expectations and alleviates some of the near term-pressure on MA insurers [HUM, ALHC, UNH, CVS, ELV, CNC]…

The White House’s biopharma tariffs announced last week [Fact Sheet] strike us as an aggressive effort to secure additional onshoring and most favored nation (MFN) pricing agreements with manufacturers, but the clock is likely ticking…

FY27 Medicare reimbursement proposals for skilled nursing facilities [ENSG, PACS] and related REITs [SBRA, OHI, LTC, CTRE], inpatient rehab facilities (IRFs) [EHC, SEM, Kindred]and inpatient psych facilities (IPFs) [UHS, ACHC] were broadly in-line with our…

FY27 Medicare reimbursement proposal for hospices [CHE, ADUS, PNTG, EHAB, BTSG, AVAH, Gentiva, Compassus, Elara] matched our expectations, reflecting a smaller aggregate increase versus FY26 but consistent with the statutory formula. While modest upside is…

While Trump said yesterday that he wants a reconciliation bill limited to funding for ICE and CBP, we think:  The odds slightly favor Republicans eventually including in the same package the administration’s ~$200 billion in defense funding to replenish stockpiles as a result of the Iran conflict.  We also think the…

As the prospects have risen for another budget reconciliation bill, so has the risk for another legislative round of healthcare spending cuts, pressuring insurers, hospitals and home care and hospice agencies as a partial pay-fors…

With government policy in a seemingly endless state of flux, we offer investors our quarterly lookahead to what we view as the most relevant catalysts across the medtech, biopharma, diagnostics, and life science tools (LST)…